SciELO - Scientific Electronic Library Online

 
vol.24 número3Hemorragia pulmonar y síndrome antifosfolípido primario: aportación de un caso y revisión de la literaturaDegeneración cerebelosa paraneoplásica como presentación de una recidiva de carcinoma de mama índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Anales de Medicina Interna

versão impressa ISSN 0212-7199

Resumo

PERAYRE BADIA, M.; LEIVA BADOSA, E.; PASTO CARDONA, L.  e  JODAR MASSANES, R.. Intermediate syndrome after organophosphate poisoning despite continuous infusion of pralidoxime. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.3, pp.129-131. ISSN 0212-7199.

Acute organophosphate poisoning leads to a cholinergic crisis secondary to an acetylcholine rise, developed by an acetylcholinesterase inhibition. In some cases, after the resolution of the initial cholinergic signs and symptoms, an intermediate syndrome occurs, characterized by a delayed development of proximal and diaphragmatic muscle paralysis. We describe a case of a 67-year-old man who developed an intermediate syndrome after oxydemeton-metryl ingestion in a suicide attempt, despite a continuous pralidoxime infusion. Several hypotheses have been developed to explain the aetiology of this intermediate syndrome (neuromuscular junction dysfunction, inadequate poisoning treatment, late beginning of the oxime administration, etc). Intermediate syndrome manifestation will depend on the organophosphate's organism persistence and its chemical structure, and also on the time elapsed between the poisoning and the antidote administration.

Palavras-chave : Organophosphates; Intermediate syndrome; Poisoning; Pralidoxime; Oxydemeton methyl.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons